HANGZHOU TIGERMED CO. H 1 (5HZ1) — Cash Flow Reinvestment Rate
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Reinvestment Rate of 1.01x as of December 2025, reinvesting €1.13 Billion (capex €214.37 Million plus investments €914.13 Million) from operating cash flow of €1.12 Billion. Explore 5HZ1 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HANGZHOU TIGERMED CO. H 1 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Also explore how large is HANGZHOU TIGERMED CO. H 1's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for HANGZHOU TIGERMED CO. H 1 (2021–2025)
Year-by-year capital reinvestment analysis for HANGZHOU TIGERMED CO. H 1. For live market cap and broader valuation context, see HANGZHOU TIGERMED CO. H 1 market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.01x | €1.13 Billion | €1.12 Billion | €214.37 Million | ▼ -74.7% |
| 2024 | 3.99x | €4.38 Billion | €1.10 Billion | €356.55 Million | ▲ +271.0% |
| 2023 | 1.08x | €1.24 Billion | €1.15 Billion | €313.76 Million | ▼ -34.2% |
| 2022 | 1.64x | €2.22 Billion | €1.36 Billion | €448.60 Million | ▼ -6.6% |
| 2021 | 1.75x | €2.49 Billion | €1.42 Billion | €368.62 Million | — |